Cetin, Esra, Mazzarino, Morgane, González-Mateo, Guadalupe T., Kopytina, Valeria, Meran, Soma ORCID: https://orcid.org/0000-0003-3408-3978, Fraser, Donald ORCID: https://orcid.org/0000-0003-0102-9342, López-Cabrera, Manuel, Labéta, Mario O. ORCID: https://orcid.org/0000-0001-5750-6983 and Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835 2023. Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection. Frontiers in Cellular and Infection Microbiology 13 , 1285193. 10.3389/fcimb.2023.1285193 |
Mazzarino, Morgane, Cetin, Esra, Bartosova, Maria, Marinovic, Iva, Ipseiz, Natacha ORCID: https://orcid.org/0000-0001-5008-8889, Hughes, Timothy R. ORCID: https://orcid.org/0000-0003-2348-3490, Schmitt, Claus Peter, Ramji, Dipak P. ORCID: https://orcid.org/0000-0002-6419-5578, Labéta, Mario O. ORCID: https://orcid.org/0000-0001-5750-6983 and Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835 2023. Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology. Frontiers in Immunology 14 , 1240679. 10.3389/fimmu.2023.1240679 |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, González-Mateo, Guadalupe T., Williams, Aled, Topley, Nicholas, Fraser, Donald ORCID: https://orcid.org/0000-0003-0102-9342, López-Cabrera, Manuel and Labeta, Mario O. ORCID: https://orcid.org/0000-0001-5750-6983 2018. Targeting toll-like receptors with soluble toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis. Kidney International 94 (2) , pp. 346-362. 10.1016/j.kint.2018.03.014 |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Colmont, Chantal S., Kift-Morgan, Ann, Köhl, Jörg, Eberl, Matthias ORCID: https://orcid.org/0000-0002-9390-5348, Fraser, Donald ORCID: https://orcid.org/0000-0003-0102-9342, Topley, Nicholas and Labeta, Mario O. ORCID: https://orcid.org/0000-0001-5750-6983 2017. Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis. Journal of the American Society of Nephrology 28 (2) , pp. 461-478. 10.1681/ASN.2015080923 |
Holst, Benjamin, Szakmany, Tamas ORCID: https://orcid.org/0000-0003-3632-8844, Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Hamlyn, Vincent, Durno, Kimberley, Hall, Judith Elizabeth ORCID: https://orcid.org/0000-0002-6770-7372 and Labéta, Mario O. 2017. Soluble toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission. Intensive Care Medicine Experimental 5 (1) 10.1186/s40635-016-0116-z |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835 and Labeta, Mario ORCID: https://orcid.org/0000-0001-5750-6983 2016. Therapeutic boosting of the immune response: turning to CD14 for help. Current Pharmaceutical Biotechnology 17 (5) , pp. 414-418. 10.2174/1389201017666160114095708 |
Shang, Limin, Daubeuf, Bruno, Triantafilou, Martha ORCID: https://orcid.org/0000-0002-8489-2602, Olden, Robin, Depis, Fabien, Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Herren, Suzanne, Dos Santos, Anaelle, Malinge, Pauline, Dunn-Siegrist, Irene, Benmkaddem, Sanae, Geinoz, Antoine, Magistrelli, Giovanni, Rousseau, Francois, Buatois, Vanessa, Salgado-Pires, Susana, Reith, Walter, Monteiro, Renato, Pugin, Jerome, Leger, Olivier, Ferlin, Walter, Kosco-Vilbois, Marie, Triantafilou, Kathy ORCID: https://orcid.org/0000-0002-7473-6278 and Elson, Greg 2014. Selective antibody intervention of toll-like receptor 4 activation through Fc γ receptor tethering. Journal of Biological Chemistry 289 (22) , pp. 15309-15318. 10.1074/jbc.M113.537936 |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Holst, Benjamin, Le Bouder, Emmanuel Jerome, Diaz, Constantinou, Ferran, Edgardo, Conraux, Laurence, Guillemot, Jean-Claude, Coles, Barbara, Kift-Morgan, Ann Patricia, Colmont, Chantal Sophie, Szakmany, Tamas ORCID: https://orcid.org/0000-0003-3632-8844, Ferrara, Pascual, Hall, Judith Elizabeth ORCID: https://orcid.org/0000-0002-6770-7372, Topley, Nicholas and Labeta, Mario Oscar ORCID: https://orcid.org/0000-0001-5750-6983 2013. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Science Translational Medicine 5 (185) , 185ra64. 10.1126/scitranslmed.3005544 |
Colmont, Chantal Sophie, Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Dioszeghy, Vincent, Le Bouder, Emmanuel, Foster, Thomas Lloyd, Jones, Simon Arnett ORCID: https://orcid.org/0000-0001-7297-9711, Labeta, Mario Oscar ORCID: https://orcid.org/0000-0001-5750-6983, Fielding, Ceri Alan ORCID: https://orcid.org/0000-0002-5817-3153 and Topley, Nicholas 2011. Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrology Dialysis Transplantation 26 (12) , pp. 4079-4090. 10.1093/ndt/gfr217 |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Holst, Benjamin, Davies, James Anthony ORCID: https://orcid.org/0000-0003-3569-4500, Colmont, Chantal Sophie, Laumonnier, Yves, Coles, Barbara, Shah, Sanjoy, Hall, Judith Elizabeth ORCID: https://orcid.org/0000-0002-6770-7372, Topley, Nicholas, Köhl, Jörg, Morgan, Bryan Paul ORCID: https://orcid.org/0000-0003-4075-7676 and Labeta, Mario Oscar ORCID: https://orcid.org/0000-0001-5750-6983 2011. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. European Journal of Immunology 41 (9) , pp. 2741-2752. 10.1002/eji.201041350 |
Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Le Bouder, Emmanuel, Colmont, Chantal Sophie, Davies, James Anthony ORCID: https://orcid.org/0000-0003-3569-4500, Richards, Peter, Coles, Barbara, George, Christopher H., Jones, Simon Arnett ORCID: https://orcid.org/0000-0001-7297-9711, Brennan, Paul ORCID: https://orcid.org/0000-0001-8792-0499, Topley, Nicholas and Labeta, Mario Oscar ORCID: https://orcid.org/0000-0001-5750-6983 2009. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. The Journal of Immunology 183 (1) , pp. 506-517. 10.4049/jimmunol.0802909 |